A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

Clinical trial NCT04521478 · COMPLETED

Trial details

NCT number: NCT04521478
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2020-11-20
Primary completion: 2024-01-10
Enrollment: 389

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.